Phase III Study of Erlotinib in Combination With Cisplatin and Gemcitabine in Advanced Non–Small-Cell Lung Cancer: The Tarceva Lung Cancer Investigation TrialU. Gatzemeier, Joachim von Pawel, A Płużańska et al.|Journal of Clinical Oncology|2007Cited by 879
FAST: a randomised phase II study of zolbetuximab (IMAB362) plus EOX versus EOX alone for first-line treatment of advanced CLDN18.2-positive gastric and gastro-oesophageal adenocarcinomaUğur Şahin, S. Al-Batran, Andriy Rusyn et al.|Annals of Oncology|2021Cited by 357